CVE-2022-30277: Bd Synapsys

Medium severity, CVSS 5.7. EPSS: 0.2% chance of exploitation in the next 30 days.

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

Affected products

• Bd Synapsys: version 4.20 only; version 4.30 only

Published 2022-06-02. Last modified 2026-06-17.